UMBC’s Jeffrey Gardner receives $1.3M from NIH to discover new treatments for fungal disease
Drug resistance is a growing problem in treating fungal disease. Jeffrey Gardner is searching for a new way to treat these infections with bacterial enzymes. It’s a new area of research for him, but “if you can find an interesting bug, with some interesting physiology,” he says, “the types of questions can really span major different areas.” Continue Reading UMBC’s Jeffrey Gardner receives $1.3M from NIH to discover new treatments for fungal disease